Mingjuan Lisa Zhang, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cytodiagnosis | 6 | 2023 | 435 | 2.210 |
Why?
|
Urothelium | 5 | 2020 | 277 | 1.880 |
Why?
|
Urologic Neoplasms | 5 | 2020 | 316 | 1.630 |
Why?
|
Urine | 5 | 2020 | 370 | 1.540 |
Why?
|
Pancreatic Cyst | 2 | 2024 | 368 | 1.190 |
Why?
|
Carcinoma | 6 | 2022 | 2375 | 1.180 |
Why?
|
Pancreatic Neoplasms | 5 | 2024 | 5257 | 0.990 |
Why?
|
Urinary Bladder Neoplasms | 4 | 2020 | 2237 | 0.840 |
Why?
|
Jaundice | 1 | 2022 | 89 | 0.830 |
Why?
|
Colitis, Ischemic | 1 | 2021 | 31 | 0.800 |
Why?
|
Digestive System | 1 | 2022 | 251 | 0.760 |
Why?
|
Enterocolitis | 1 | 2021 | 102 | 0.740 |
Why?
|
Digestive System Diseases | 1 | 2022 | 147 | 0.730 |
Why?
|
Body Fluids | 1 | 2021 | 319 | 0.680 |
Why?
|
Cell Nucleus | 3 | 2017 | 2969 | 0.660 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2018 | 109 | 0.620 |
Why?
|
Cystadenoma, Serous | 1 | 2018 | 102 | 0.610 |
Why?
|
Osteosarcoma | 1 | 2023 | 881 | 0.590 |
Why?
|
Laboratories | 1 | 2021 | 463 | 0.580 |
Why?
|
Urinary Tract | 1 | 2020 | 308 | 0.580 |
Why?
|
Mediastinal Neoplasms | 1 | 2020 | 421 | 0.580 |
Why?
|
Adenocarcinoma | 4 | 2023 | 6352 | 0.570 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2017 | 190 | 0.520 |
Why?
|
Surgical Instruments | 1 | 2018 | 395 | 0.520 |
Why?
|
Glaucoma | 2 | 2015 | 1159 | 0.510 |
Why?
|
Hypoglycemia | 1 | 2022 | 861 | 0.510 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2022 | 1039 | 0.510 |
Why?
|
Eye Neoplasms | 1 | 2017 | 313 | 0.500 |
Why?
|
Cytoplasm | 2 | 2017 | 1539 | 0.500 |
Why?
|
Hematuria | 1 | 2016 | 235 | 0.500 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2022 | 989 | 0.460 |
Why?
|
Trabeculectomy | 1 | 2015 | 162 | 0.460 |
Why?
|
Phacoemulsification | 1 | 2015 | 149 | 0.460 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2017 | 802 | 0.450 |
Why?
|
Soft Tissue Neoplasms | 1 | 2023 | 1363 | 0.450 |
Why?
|
Intraocular Pressure | 2 | 2015 | 1274 | 0.410 |
Why?
|
Sarcoma | 1 | 2023 | 1897 | 0.390 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 1169 | 0.390 |
Why?
|
Lymphoma | 1 | 2020 | 1873 | 0.390 |
Why?
|
Bone Neoplasms | 1 | 2023 | 2525 | 0.370 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1634 | 0.340 |
Why?
|
Cataract | 1 | 2015 | 834 | 0.340 |
Why?
|
Flow Cytometry | 1 | 2020 | 5974 | 0.340 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1831 | 0.310 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3086 | 0.280 |
Why?
|
Biopsy | 5 | 2023 | 6757 | 0.270 |
Why?
|
Colonic Neoplasms | 3 | 2022 | 2538 | 0.270 |
Why?
|
Therapeutic Irrigation | 2 | 2017 | 301 | 0.270 |
Why?
|
Neoplasm Staging | 1 | 2020 | 11007 | 0.260 |
Why?
|
Triage | 2 | 2023 | 976 | 0.250 |
Why?
|
Cyst Fluid | 1 | 2024 | 76 | 0.230 |
Why?
|
Humans | 37 | 2024 | 744220 | 0.220 |
Why?
|
Carcinoembryonic Antigen | 1 | 2024 | 347 | 0.220 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9275 | 0.210 |
Why?
|
Aged | 14 | 2021 | 163253 | 0.200 |
Why?
|
Cytological Techniques | 1 | 2023 | 219 | 0.200 |
Why?
|
Diagnosis, Differential | 3 | 2022 | 12961 | 0.190 |
Why?
|
Erythroblasts | 1 | 2021 | 150 | 0.190 |
Why?
|
Clinical Competence | 1 | 2016 | 4687 | 0.180 |
Why?
|
Middle Aged | 14 | 2022 | 213367 | 0.180 |
Why?
|
Male | 17 | 2023 | 350027 | 0.180 |
Why?
|
Hematologic Tests | 1 | 2021 | 240 | 0.180 |
Why?
|
Inflammation | 1 | 2019 | 10634 | 0.180 |
Why?
|
Erythroid Cells | 1 | 2021 | 238 | 0.180 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 48 | 0.180 |
Why?
|
Facial Neoplasms | 1 | 2020 | 121 | 0.170 |
Why?
|
Nuclear Envelope | 1 | 2020 | 172 | 0.170 |
Why?
|
Barrett Esophagus | 1 | 2023 | 494 | 0.160 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2022 | 505 | 0.160 |
Why?
|
Urinalysis | 1 | 2020 | 369 | 0.160 |
Why?
|
Gastritis | 1 | 2019 | 196 | 0.150 |
Why?
|
Orbital Neoplasms | 1 | 2020 | 225 | 0.150 |
Why?
|
Female | 16 | 2022 | 380197 | 0.150 |
Why?
|
Physicians | 1 | 2016 | 4564 | 0.150 |
Why?
|
Hematology | 1 | 2021 | 221 | 0.150 |
Why?
|
Lymphocyte Count | 1 | 2020 | 793 | 0.150 |
Why?
|
Colonic Polyps | 1 | 2022 | 542 | 0.150 |
Why?
|
Pathology | 1 | 2020 | 272 | 0.150 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1692 | 0.140 |
Why?
|
Education, Distance | 1 | 2020 | 251 | 0.140 |
Why?
|
Aged, 80 and over | 6 | 2023 | 57768 | 0.140 |
Why?
|
Predictive Value of Tests | 3 | 2022 | 15070 | 0.140 |
Why?
|
Specimen Handling | 1 | 2021 | 694 | 0.140 |
Why?
|
Tumor Microenvironment | 4 | 2022 | 3584 | 0.140 |
Why?
|
Pancreas | 1 | 2022 | 1686 | 0.130 |
Why?
|
Diarrhea | 1 | 2022 | 1347 | 0.130 |
Why?
|
BK Virus | 1 | 2016 | 129 | 0.130 |
Why?
|
Stomach | 1 | 2019 | 697 | 0.130 |
Why?
|
Microscopy | 1 | 2020 | 903 | 0.130 |
Why?
|
Trabecular Meshwork | 1 | 2015 | 99 | 0.130 |
Why?
|
Neurofibromatosis 1 | 1 | 2020 | 568 | 0.130 |
Why?
|
Adult | 10 | 2022 | 214035 | 0.120 |
Why?
|
Lymphocytes | 1 | 2022 | 2617 | 0.120 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2020 | 2649 | 0.120 |
Why?
|
Polyomavirus Infections | 1 | 2016 | 197 | 0.120 |
Why?
|
Observer Variation | 2 | 2018 | 2593 | 0.120 |
Why?
|
Europe | 1 | 2020 | 3339 | 0.120 |
Why?
|
Tumor Virus Infections | 1 | 2016 | 452 | 0.110 |
Why?
|
Esophageal Neoplasms | 1 | 2023 | 1582 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 964 | 0.110 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6773 | 0.110 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3474 | 0.100 |
Why?
|
Adenoma | 1 | 2022 | 2174 | 0.100 |
Why?
|
Colon | 1 | 2019 | 1772 | 0.100 |
Why?
|
Colitis | 1 | 2019 | 1170 | 0.100 |
Why?
|
Myelodysplastic Syndromes | 1 | 2021 | 1352 | 0.100 |
Why?
|
Antigens, CD | 1 | 2021 | 4026 | 0.100 |
Why?
|
Bone Marrow | 1 | 2021 | 2944 | 0.090 |
Why?
|
Forkhead Transcription Factors | 3 | 2022 | 1613 | 0.090 |
Why?
|
Homeodomain Proteins | 1 | 2020 | 2422 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2020 | 2726 | 0.090 |
Why?
|
Chromatin | 1 | 2020 | 2934 | 0.080 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2022 | 2041 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6893 | 0.080 |
Why?
|
Cohort Studies | 4 | 2020 | 40559 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 4033 | 0.070 |
Why?
|
Retrospective Studies | 4 | 2024 | 77426 | 0.070 |
Why?
|
Quality Improvement | 1 | 2021 | 3746 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3328 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14726 | 0.060 |
Why?
|
Logistic Models | 1 | 2020 | 13409 | 0.060 |
Why?
|
Prognosis | 3 | 2022 | 29050 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2016 | 3690 | 0.060 |
Why?
|
Stents | 1 | 2015 | 3280 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11368 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8628 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5442 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5221 | 0.060 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3132 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2020 | 19907 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3239 | 0.050 |
Why?
|
MutS Homolog 2 Protein | 1 | 2022 | 200 | 0.050 |
Why?
|
Coloring Agents | 1 | 2023 | 566 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8387 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 13885 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2022 | 426 | 0.040 |
Why?
|
Mucins | 1 | 2022 | 564 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 9960 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2016 | 21752 | 0.040 |
Why?
|
Biopsy, Fine-Needle | 1 | 2022 | 1094 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13096 | 0.040 |
Why?
|
Computer-Assisted Instruction | 1 | 2020 | 365 | 0.040 |
Why?
|
Faculty | 1 | 2020 | 386 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39045 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3294 | 0.030 |
Why?
|
Young Adult | 2 | 2021 | 56436 | 0.030 |
Why?
|
Photography | 1 | 2017 | 520 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2021 | 63119 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2021 | 4776 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2023 | 2948 | 0.030 |
Why?
|
Prospective Studies | 1 | 2014 | 53280 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 35423 | 0.020 |
Why?
|
Child | 1 | 2017 | 77679 | 0.020 |
Why?
|
Adolescent | 1 | 2017 | 85759 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4477 | 0.020 |
Why?
|
DNA Methylation | 1 | 2020 | 4289 | 0.020 |
Why?
|
Transcription Factors | 1 | 2020 | 12207 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 8950 | 0.010 |
Why?
|
United States | 1 | 2023 | 69867 | 0.010 |
Why?
|